Form 4 for BSX Boston Scientific
Accepted 2023-04-04 00:00:00 ET · period of report 2023-04-03 · accession 0001225208-23-004618 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-04-04 | 2023-04-03 | BSX | WICHMANN DAVID S | Dir | A - Grant | $0.00 | +41 | 32.7K | +0.1% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-03 | A | A | 41 | $0.00 | 32,654 | D | — | — | (F1) Restricted stock granted in lieu of 100% of cash compensation, vesting in full upon the next annual meeting of stockholders. Reflects a value of $2,083.33, divided by the closing price of common stock on the date of grant. |